The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text)  

The post RCT: The effect of azithromycin on structural lung disease in infants with cystic fibrosis. appeared first on Links Medicus.